Amphastar Escapes $1B Momenta, Sandoz Infringement Suit
A Massachusetts federal jury on Friday sided with Amphastar Pharmaceuticals in a patent battle with Momenta Pharmaceuticals and Sandoz, finding that Momenta's patent for a generic blood thinner was invalid and...To view the full article, register now.
Already a subscriber? Click here to view full article